Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385667427> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4385667427 endingPage "e8910978" @default.
- W4385667427 startingPage "e8910978" @default.
- W4385667427 abstract "Topic: 13. Myeloma and other monoclonal gammopathies - Biology & Translational Research Background: MM is still an incurable disease and osteoclast-mediated bone destruction is a hallmark. Existing agents effectively reduce the number of osteoclasts (OCs) and prevent bone-related diseases but have little effect on overall survival. Investigating the potential mechanisms and developing novel agents against bone lesions is essential. Aims: To investigated the contributions of MM-derived exosomal lncRNAs to osteogenic differentiation and explored through which mechanisms they fulfilled this function and the role of m5C modification in it. Methods: OCs differentiation, bone resorption, bone lesions formation induced by exosomal MALAT1 of MM cells were confirmed by RNA fluorescent in situ hybridization, Tartrate-resistant acid phosphatase (TRAP) staining, von Kossa, and xenograft model in vivo. The mechanism was demonstrated by methylated RNA immunoprecipitation, and RNA stability detection. Results: To explore the possible roles of lncRNAs in bone lesions formation, exosomes were isolated from U266 cells and high‐throughput sequencing was performed. It was found that MALAT1 expression was the highest. Then, MALAT1 expression was examined in MM cohorts. Intriguingly, MALAT1 was significantly increased in MM cells compared with normal plasma (NP) cells in the GSE24080 and GSE5900 patient cohorts (Figure 1A). The FISH examination revealed an obvious abundance of MALAT1 in bone marrow of MM patients (Figure 1B). To demonstrate whether MALAT1 in U266 cells acts on macrophages via incorporating into exosomes, we labeled isolated exosomes with PKH26 dye and MALAT1 with GFP from U266 cells. The labeled exosomes were subsequently added and incubated with RAW264.7 cells. As presented in figure 1C, the majority of the recipient cells exhibited a yellow signal in cytoplasm under the confocal microscope, suggesting that MALAT1 could be packaged into exosomes and swallowed by RAW264.7 cells. We directly influence MALAT1 expression in RAW264.7 cells. Overexpression of MALAT1 could upregulate RANKL expression and increase TRAP-positive OCs and mineralized nodules, while the knockdown of MALAT1 showed a reverse trend (Figure 1D-F). The ability of MM exosomes in bone destruction was then verified in vivo by injecting U266 cells, U266 cells plus MM exosomes, and U266 cells plus MALAT1-knockdown-exosomes into the tail vein of NOG mice. The extent of the bone disease in each model was assessed by micro-CT. Parametric analysis using microCT revealed a significant decrease in the bone volume (bone volume/tissue volume) by exosomes, while when injecting MALAT1-knockdown-exosomes, we observed a reverse trend (Figure 1G). Recent studies focused on the function of RNA modification in regulating lncRNAs expression. We found that MALAT1 level was strongly correlated with NSUN2 (R2=0.758) and YBX1 (R2=0.748) levels (Figure 1H). To test whether and how m5C modification regulates MALAT1 expression, U266 cells were transfected with siRNA targeting NSUN2. Knockdown of NSUN2 significantly reduced the m5C levels of MALAT1 (Figure 1I). A rescue experiment showed that MALAT1 expression and stability increased by NSUN2 were reversed when transfected with YBX1 siRNA (Figure 1J). Summary/Conclusion: Our study demonstrates that myeloma cells-derived exosomal lncRNA MALAT1 might involve in bone lesions formation, which is modulated by NUNS2- mediated m5 C modifications.Keywords: Myeloma, Bone disease, Epigenetic" @default.
- W4385667427 created "2023-08-09" @default.
- W4385667427 creator A5028533513 @default.
- W4385667427 creator A5050347190 @default.
- W4385667427 date "2023-08-01" @default.
- W4385667427 modified "2023-09-27" @default.
- W4385667427 title "P843: ABERRANT M5C MODIFICATION OF LNCRNA MALAT1 IS ASSOCIATED WITH BONE LESIONS FORMATION IN MULTIPLE MYELOMA" @default.
- W4385667427 doi "https://doi.org/10.1097/01.hs9.0000970276.89109.78" @default.
- W4385667427 hasPublicationYear "2023" @default.
- W4385667427 type Work @default.
- W4385667427 citedByCount "0" @default.
- W4385667427 crossrefType "journal-article" @default.
- W4385667427 hasAuthorship W4385667427A5028533513 @default.
- W4385667427 hasAuthorship W4385667427A5050347190 @default.
- W4385667427 hasBestOaLocation W43856674271 @default.
- W4385667427 hasConcept C104317684 @default.
- W4385667427 hasConcept C134018914 @default.
- W4385667427 hasConcept C142724271 @default.
- W4385667427 hasConcept C145059251 @default.
- W4385667427 hasConcept C16930146 @default.
- W4385667427 hasConcept C185592680 @default.
- W4385667427 hasConcept C202751555 @default.
- W4385667427 hasConcept C203014093 @default.
- W4385667427 hasConcept C20518536 @default.
- W4385667427 hasConcept C2776033226 @default.
- W4385667427 hasConcept C2776364478 @default.
- W4385667427 hasConcept C2779134362 @default.
- W4385667427 hasConcept C2780007613 @default.
- W4385667427 hasConcept C502942594 @default.
- W4385667427 hasConcept C55493867 @default.
- W4385667427 hasConcept C62203573 @default.
- W4385667427 hasConcept C673006 @default.
- W4385667427 hasConcept C67705224 @default.
- W4385667427 hasConcept C71924100 @default.
- W4385667427 hasConcept C86803240 @default.
- W4385667427 hasConcept C95444343 @default.
- W4385667427 hasConceptScore W4385667427C104317684 @default.
- W4385667427 hasConceptScore W4385667427C134018914 @default.
- W4385667427 hasConceptScore W4385667427C142724271 @default.
- W4385667427 hasConceptScore W4385667427C145059251 @default.
- W4385667427 hasConceptScore W4385667427C16930146 @default.
- W4385667427 hasConceptScore W4385667427C185592680 @default.
- W4385667427 hasConceptScore W4385667427C202751555 @default.
- W4385667427 hasConceptScore W4385667427C203014093 @default.
- W4385667427 hasConceptScore W4385667427C20518536 @default.
- W4385667427 hasConceptScore W4385667427C2776033226 @default.
- W4385667427 hasConceptScore W4385667427C2776364478 @default.
- W4385667427 hasConceptScore W4385667427C2779134362 @default.
- W4385667427 hasConceptScore W4385667427C2780007613 @default.
- W4385667427 hasConceptScore W4385667427C502942594 @default.
- W4385667427 hasConceptScore W4385667427C55493867 @default.
- W4385667427 hasConceptScore W4385667427C62203573 @default.
- W4385667427 hasConceptScore W4385667427C673006 @default.
- W4385667427 hasConceptScore W4385667427C67705224 @default.
- W4385667427 hasConceptScore W4385667427C71924100 @default.
- W4385667427 hasConceptScore W4385667427C86803240 @default.
- W4385667427 hasConceptScore W4385667427C95444343 @default.
- W4385667427 hasIssue "S3" @default.
- W4385667427 hasLocation W43856674271 @default.
- W4385667427 hasLocation W43856674272 @default.
- W4385667427 hasOpenAccess W4385667427 @default.
- W4385667427 hasPrimaryLocation W43856674271 @default.
- W4385667427 hasRelatedWork W145261980 @default.
- W4385667427 hasRelatedWork W1978112005 @default.
- W4385667427 hasRelatedWork W2038751394 @default.
- W4385667427 hasRelatedWork W2100692480 @default.
- W4385667427 hasRelatedWork W2159395835 @default.
- W4385667427 hasRelatedWork W2366388222 @default.
- W4385667427 hasRelatedWork W2400014005 @default.
- W4385667427 hasRelatedWork W2784211356 @default.
- W4385667427 hasRelatedWork W308437994 @default.
- W4385667427 hasRelatedWork W3196612340 @default.
- W4385667427 hasVolume "7" @default.
- W4385667427 isParatext "false" @default.
- W4385667427 isRetracted "false" @default.
- W4385667427 workType "article" @default.